求人・転職情報

■ 職務内容 / Job Description
Clinical Regulatory Writer (CReW) is responsible for the authoring of clinical-regulatory documents and submission packages that communicate the evidence base of product knowledge in a credible, consistent and compliant way.
CReW leads the authoring of the clinical parts of documents such as CSP / MICF / CSR / IB / CTD / Regulatory defences, in line with the project communication strategy, and ensure quality and efficiency in delivery. For CSP/MICF/IB, CReW centralize and coordinate those developments using external vendors across clinical studies.
CReW also leads or contributes the authoring of the clinical parts of the briefing documents for PMDA consultations to improve communication quality of documents. CReW reviews other clinical documents with the purpose of facilitating the translation of Target Product Claims into a fully-supported proposed product label, and to improve communication quality of documents.

本ポジションは、Medical Affairsの戦略的最適化を担い、戦略、VPS（価値・エビデンス・アウトカム・出版・科学コミュニケーション）、メディカルエデュケーション、フィールドメディカルの4機能間の連携を促進します。業務効率と効果向上のための新基準やツールの開発・実装を支援し、タイムラインや予算管理を行います。業界動向を活用し、業務プロセスの改善提案や課題分析を実施、組織改善をリードします。グローバルとローカルの最適バランスを目指し、リソース管理やプロセス開発を推進。社内他部署と連携し一貫性あるメディカルアクションプランの策定を支援します。コミュニケーション計画の立案・管理や活動効果の指標設定と最適化も担当。クロスファンクショナルな課題解決をリードし、会社全体目標と医療施策の整合を図ります。交渉力や文化的感受性を活かし他部署と協働し、メディカルガバナンスの整備やコンプライアンス遵守を推進。メディカルアフェアーズの変革と高パフォーマンスチームの構築に重要な役割を果たし、社内外への情報発信を通じて貢献します。

当日本ファーマコエピデミオロジーチームは、地域横断型の安全性監視部門です。全世界に展開する参天製品や治験品の安全性を戦略的に監視する役割を果たしています。

＜ポジションの役割/PR＞
People centricityのマインドセットの下、当部門が保有する豊富な安全性・有効性データを活用し、規制対応を越えて、医療現場の医師・患者さんに安心と信頼を届けるための積極的な情報発信をリードして頂きます。


JOB DESCRIPTION
【業務内容】
・自社製品（医薬品及び医療機器）の安全性に関わる事項について、開発相及び市販後におけるカンパニーポジションを構築する。
・安全監視活動を効果的に実施するために、メディカルエバリュエーション、コンプライアンス、オペレーションの各機能と連携する。
・様々な研究データを活用して医薬品・医療機器の安全性・有効性を分析する薬剤疫学的アプローチにより、開発相及び市販後において、自社製品のベネフィット・リスクバランスを評価する。
・医学的、科学的バックグラウンドとスキルを活用し、自社製品の適正使用を促進する。
・安全性に関わる戦略を構築し、潜在的なSafety issueを特定し、適切な安全性監視活動を計画、実行する。
・RMP、PSUR、DSUR、CCDSの安全性パートなど、安全性に関わるグローバル文書十分な品質のもと作成し、遅滞なく各規制当局へ提出されていることを監督する。
学会発表、論文等のpublicationを主導する。
・GSVEM (Global Safety Vigilance Evaluation Meeting)を主宰し、安全性に関わるトピックについて、高質かつ適時の提案がなされるようサポートする。
・ファーマコエピデミオロジーグループが主管する製造販売後調査の計画、実行、完了を監督する。
・安全性シグナル、社外リアルワールドデータ等の外部データソース探索に関連する安全性監視活動の標準業務手順書（SOP）を作成、レビュー、アップデートし、規制変更に対応する。
・安全性監視の全般プロセス、方針、手順の更なる改善に向けて意見具申する。
・安全性監視システムに関わる内外の査察及び査察後対応に参画し、不適合事項に対処し、CAPAを効果的に立案、実行を保証する。

Job Purpose & Key Responsibilities
Provides medical and scientific support to the Therapeutic Area (TA) Business Units of Rx, most notably, sales and marketing. Ensures that allcompany scientific, promotional and commercial activities respect internal, national and international ethical guidelines.

Key Accountabilities/Responsibilities:
Provide medical advice and input in the development and implementation business strategies related to TA business.
Support Medical Lead on the development and implementation of the medical plan which is consistent with the global and country business plans for TA Business Unit.
Ensure adequate medical information and customer support for health care professionals in the daily usage of GSK brands.
Develop and facilitate relations with key opinion-leaders and key authorities and within the industry in general at a country level.
Optimize cross-functional support needs in the organization, ensuring effective communication between medical and brand team.
Provide business development support as appropriate, in terms of giving technical advice and input on all product development and licensing opportunities.
Ensuring compliance and medical governance in training on relevant SOPs.
Ensuring promotional/training materials to be in compliance with internal and external regulatory requirement.
Managing issues that arise that may adversely affect business and patients.
Assuring compliance with corporate and industry standards and procedures for conduct of clinical activities, including studies and research grants.

Job Purpose
GSKの製造拠点におけるGSK生産システム（GPS）の戦略策定と実行をリードし、サイト全体での品質・安全・コスト・デジタルイノベーション等の業務成績向上を推進します。サイト経営陣と強固な関係を築き、GPSの能力向上を通じて戦略展開を支援し、全階層・全機能での継続的改善（CI）マインドセットの定着を図ります。


1. Strategic Planning
今市サイトが年間プログラムを定義・明確化できるよう支援し、ブレークスルー目標や戦略的課題に照らして優先順位付けが適切に行われるよう促進します。
サイト経営陣（SLT）と連携し、継続的改善（CI）施策や活動のための適切なチャネルを構築して、正しい戦略と方向性にフォーカスさせます。

2. オペレーショナル・ビジネス
パフォーマンス管理システムを主導・展開し、目標達成あるいはそれ以上のパフォーマンスを維持するためのトラッキングとガバナンスを確立します。
戦略立案や問題解決の支援に向け、データ分析、自動化、デジタル技術を活用します。

3. コンプライアンスおよび手順実行
今市サイトのGPS成熟度目標に沿って、GPS基準が確実に組織に定着するよう実行・フォローします。

4. 人材マネジメントと能力開発
今市サイト全体で一貫したGPS能力を構築（例：パフォーマンス管理、リーンリーダーシップ、問題解決、ムダ排除 等）します。
今市サイト経営陣と協働し、優れたリーダーおよびチームの育成・定着を推進します。
自チーム内のチェンジプロジェクトを遂行し、他チームが自走できるよう支援します。
サイト全体で戦略展開がGPSおよびPSM目標と整合するよう、あらゆるレベルで人員を動員（プッシュ・プル）します。
個々のメンバーをエンパワーし、コーチングや指導を通じて各自が役割を全うし、持続可能な変革を実現できるよう導きます。


注記（略語）
GPS：GSK Production System（GSK生産システム）
SLT：Site Leadership Team（サイト経営陣）
PSM：Process Safety Management（プロセス安全管理）

■Job Purpose
Be accountable for leadership and development of site GPS (GSK Production System) strategy and implementation.  Build strong relationships across the site to deliver the business strategy and improve business performance (quality, safety, cost and digital innovation), GPS lead provide teaching and coaching to site leadership team to enable the site to deploy its strategy by building GPS capability to achieve maturity and a CI mindset across all levels and functions.

■Key Responsibilities
1. Strategic Planning
・Facilitate the site to define and articulate its annual programs.  Ensure the annual programmes are appropriately prioritized in line with breakthrough objectives and strategic imperatives. 
・Lead the site with the SLT to focus on the right strategy and direction by a channel for CI initiatives and activities. 

2. Operational Business
・Lead and deploy performance management systems, in order to track, on or above target performance.  Ensure appropriate governance and rigor in place. 
・Leverage Data Analytics, Automation and Digital technology to support strategy development and problem solving. 

3. Compliance and Procedural Implementations
・Ensure GPS standards are embedded as per site GPS Maturity targets.    

4. People Management & Development
・Build broad and consistent GPS capabilities throughout the site, from a strategic and operational perspective (e.g. performance management systems, lean leadership capability, problem solving capability, waste elimination capability, etc.) 
・In partnership with SLT, develop, drive and evolve the establishment of outstanding leaders and teams across the site. 
・Deliver change projects within own team and support others to do the same for themselves.
・Lead and mobilise (push and pull) across the site, at all levels, to ensure strategy deployment is prioritized and aligned to GPS and PSM goals.
・Empower, coach and guide individuals in order for them to fulfill their roles and deliver effective, sustainable change. 

■Position Summary
You will lead epidemiology initiatives in Japan to inform development and lifecycle decisions. You will partner across clinical, safety, regulatory and commercial teams. You will shape study design, manage external partnerships, and translate real-world evidence into clear recommendations. We value curiosity, collaboration, and a practical approach that balances scientific rigour with timely decision-making. Join us to grow your career while helping GSK unite science, technology and talent to get ahead of disease together.

■Responsibilities
This role will provide YOU the opportunity to lead key activities to progress YOUR career. These responsibilities include some of the following:- Lead design, delivery and interpretation of epidemiology studies and real-world evidence projects in Japan.- Provide clear epidemiologic input to cross-functional teams including clinical development, safety, regulatory and market access.- Manage external partnerships and vendors to access data, deliver studies and ensure quality and timelines.- Produce study documents and outputs: protocols, analysis plans, final reports, regulatory input and scientific communications.- Represent GSK in scientific and regulatory discussions in Japan and with external experts.- Mentor colleagues and contribute to knowledge sharing and process improvements across the Epidemiology team.

[Job Purpose]
The Japan Vaccine Development Lead (J-VDL) is accountable for a vaccine development in Japan to ensure delivery differentiated vaccines of value for patients, stakeholders and markets in Japan. The J-VDL serves as the asset level point-of-contact for Vaccine Development Leader (=VDL), and asset single point of contact to Japan senior management and Japan governance board. JVDL must work closely with VDL not only successful launch for Japan but also overall success for GSK Global as one of the key leaders in Global Vaccine Development Team (=VDT).
[Key Responsibilities]
• Provide leadership and collaborates with the central Vaccine Development Team (VDT) to create overall integrated development strategies that support optimal medicine development for Global as well as Japan, including Integrated Evidence Plan (IEP) and Vaccine Profile. Serves as the asset level point-of-contact for the central Vaccine Development Leader (VDL).
• Acts as a single point of accountability for all aspects of a vaccine development in Japan from initiation of Japan development to launch in Japan. Provide clinical leadership and asset/disease expertise for the clinical trial program and indications in scope
• Delivers differentiated vaccines of value for patients, stakeholders and markets in Japan on time within budget, through an evidence package that supports regulatory approval, market access, and product life cycle in Japan.
• Provide Matrix Leadership in Japan (i.e. Japan Vaccine Development Team) to ensure integrated approach, robust planning, and execution oversight. Also supports differentiated development for team members; owns the performance of J-VDT and partners with line managers to drive performance. Serves as the single accountable decision maker to resolve disputes among the J-VDT.
• Works closely with the Japan Early Development Leader (J-EDL) as well as Japan Medical Lead (J-MAL) and Japan Commercial Lead (JCL) to ensure a smooth transition between the J-EDL (accountable from C2CS to initiation of Japan development) to J-VDL (accountable from initiation of Japan development to the first approval in Japan) and from J-VDL to J-MAL/JCL (accountable after the first approval in Japan).
• Asset single point of contact and spokesperson to Japan senior management and Japan governance board (e.g. Portfolio Investment Board Japan).
• Proactively identifies unmet medical needs that could be addressed through line extensions in Japan. Prioritizes and maximizes the asset’s portfolio options including developing multiple indications in Japan.
• Responsible for making recommendations to TAL/IET Leader and senior stakeholders on benefit risk assessment, Go/No-go criteria, and Clinical PoS for the program in scope
• To create the communication strategy and represent GSK externally and keep good relationship with Regulatory and government organisations
• Ministry of Health, Labor, and Welfare, PMDA
• Japanese Government (Cabinet minister, Minister office)
• National Center, Researech Institute (National Cancer Hospital etc) Scientific Societies, EEs
• Patient Groups
• CRO（PPD）
• Ensures quality & compliance oversight in line with R&D expectations and project needs; assures quality of data and science. Ensures excellence in execution of all governance processes, including oversight of all studies, pharmacovigilance, scientific engagement and promotional practices.
• J-VDL is accountable for delivering and managing the asset resourcing plan in Japan. In addition, the J-VDL is accountable for managing the asset budget in Japan.

【Job Details】
▶Basic purpose of the job:
Lead the Market Development group to drive Above-Market Growth and fully leverage the value of key pipeline assets within TA-Obesity and Liver Health, particularly survodutide (Obesity/MASH).
He/She is responsible to developing the end-to-end market development strategy for directly executing key market development initiatives, while also leading and orchestrating cross‑functional members who are accountable for other market development related projects. Through strategic leadership and hands‑on execution, the role ensures the creation of the necessary market conditions and delivery of critical initiatives that maximize the TA portfolio’s potential and enable the performance maximization of Must‑Win Assets.

▶Accountabilities - Related performance indicators
1. Market Development Strategy
・Develop and lead a comprehensive market development strategy that addresses the full patient journey to maximize the potential of survodutide across Obesity and MASH. Ensure the strategy is fully aligned with the local asset strategy to maintain strategic consistency and coherence across functions.
・Continuously monitor and interpret the evolving market environment—including clinical trends, diagnostic pathways, regulatory dynamics, competitive activities, and stakeholder behaviors—and integrate these insights to refine and strengthen the market development strategy.

- Strategy Quality and Completeness: timely delivery; clear articulation of priority barriers & opportunities grounded in validated insights; alignment across Global Brand Plan (GBP), local asset strategy
- Insight‑Driven Strategy Refinement: timely (e.g., quarterly) strategy refresh to reflect latest status
- Strategic prioritization & focus: balance strategic investment with impact and viability

2. Cross-Functional Leadership & Collaboration & Execution
・Lead and collaborate with cross-functional teams(e.g., Medicine, Marketing, MAHA and Corporate Affairs) to design and execute comprehensive, insight-driven market development initiatives. Ensure each initiative has a clearly defined objective, owner, and contribution to the overall market development strategy, enabling coherent and focused execution across functions.
・Establish and lead a focused cross‑functional governance structure for market development that enables deep strategic discussions, timely prioritization and course‑correction, and proactive action‑tracking. Ensure that governance forums drive alignment, resolve cross‑functional issues, accelerate decision‑making, and maintain strategic consistency across all market development activities.

- Cross‑Functional Alignment & Engagement
- Governance Quality & Effectiveness
- Initiative Clarity & Execution Discipline (including execution rate)
- Collaboration, Influence & Leadership Behavior

3. Strategic Project Leadership
・Act as the strategic lead for key projects assigned by the TA Head, ensuring end‑to‑end leadership from scoping to execution. Drive cross‑functional alignment, clarity of roles, and seamless coordination across stakeholders to enable timely, high‑quality delivery of project objectives.
・Lead project planning, prioritization, and issue resolution with cross‑functional team members. Proactively identify risks, escalate where appropriate, and course‑correct to keep projects on track.
・Serve as the central orchestrator who maintains project momentum, facilitates decision‑making, ensures high‑quality deliverables, and keeps senior leadership informed through clear communication and structured progress updates.

- Project Delivery & Timeliness
- Quality of Project Outputs (vendor management)
- Cross-Functional Alignment & Engagement
- Impact of Strategic Projects

▶Regulatory and / or Organizational Requirements:
・Ensure all tasks are carried out in accordance with respective applicable BI Standard Operating Procedures (SOPs), BI Code of Conduct, BI processes and regulatory requirements. Ensure that all interactions and engagements are carried out with the highest ethical and professional standards and that all work is accomplished with quality and in accordance with BI values as well as complying with local, and where relevant international law e.g. Data Protection Law of Japan / GDPR EU
・Output documents: Quarterly TA update report, contributions to CDP/IEP, updated cost tracking sheets, local integrated brand plans

▶Job Complexity:
・Strong strategic thinking and ability to establish strong working relationship with stakeholders to effectively work cross functionally.
・Provides strong leadership in guiding members and strong vendor management skills to plan and execute initiatives that are aligned to the overall strategy.

▶Interfaces*
Head of TA, J-TALC, Asset Team, Medicine, MAHA, Corporate Affairs, Integrated brand team, Corporate Brand Team

▶Job Expertise:
Full understandings of regulatory and compliance requirement in clinical development and medical affairs

▶Job Impact:
Market Development as defined as Critical Strategic Priorities for 2026 and Beyond, in Long-Term Forecast and Budget cycle guideline to drive above-market Growth

Basic purpose of the job

Based on sound medical knowledge, this role defines the local Patient Safety & Pharmacovigilance (PSPV) strategy not aonly for the delegated asset (AT) but also other products as needed and ensures the consistent implementation of the BI risk mitigation strategy to safeguard patients and / or clinical trial subjects by providing benefit/risk (B/R) expertise to the cross-functional teams based on the framework provided by Global PSPV .
Together with the LPSL, the local Patient Safety Physician (PSP) ensures by contributing to the local PSPV strategy and by responsibly taking care of delegated parts of the local PSPV system to establish and maintain a high-quality local PSPV system which is compliant with external regulations and internal processes.

Accountabilities
As an expert of benefit/risk (B/R) profile, which are assessed by global BR team and aligned among global and local, engage to take safety assurance measures such as preparation of J-RMP, proper use of drugs and closely work with evidence/asset team by providing B/R knowledge and work with global team by inputting local needs/insight.
ž -Lead to prepare local Risk management Plans in response to Japanese specific requirements (e.g. country-specific format) and content in liaison with GPV functions.
ž -Implementation and progress of global risk minimization measures, lead to prepare local RMP development and implementation not only for the delegated asset (AT) but also other products as needed. Provide PV input and insights to local labelling documents and educational materials (e.g. SPC, PIL) in time and quality.
ž -Perform local safety data monitoring not only for the delegated asset (AT) but also other products as needed. Timely information of the respective PVWG Chairperson on any relevant new safety information received from local sources for BI products or for products of the same class.
ž -Promote implementation of safety assurance measure such as proper use of drug, including preparation of guidelines for them in collaboration with stakeholders (e.g.LRA, legal &complaince)
ž -Perform Medical Quality Review of all fatal / life-threatening cases as needed and defines appropriate follow-up measures. Complete ‘fatal case investigation’ report as needed.

Manage health authority requests, potential safety issues and / or crisis management not only for the delegated asset (AT) but also other products as needed and together with global/local stakeholders.

Contribute to the PSPV Culture, Local PSPV Strategy & the establishment and maintenance of a high-quality local PSPV system, Review controlled documents (e.g. PV Working Instruction, PV Repository, applicable sections in PSMF annexes, local SOPs, etc.) also contribute to Japan initiatives to promote Patient Safety & Pharmacovigilance concepts and conduct PV trainings, where the training needs were identified, for internal and external customers.

To be ready for inspection and support to management of non-compliance
-Reporting of non-compliances as soon as becomes aware of the issue and Contribute to investigate non-compliances and associated CAPA (Corrective and Preventive Actions) activities. Take over CAPA Lead Function, if required.
-Establish and support local inspection readiness, participate in PV audits and PV/GPSP/GCP inspections.

Support the implementation activities to enhance PV compliance culture and PV awareness at local level of the organization in line with global recommendations

Proactively cooperation with Global PSPV on any upcoming new regulations or BI processes to assess the local impact and their implementation within the team.
-Contribute to seting up/optimizing of local PSPV processes including the takeover of subtasks e.g. creation/revision of the related documentation (Standard Operating Procedures (SOPs), Local PV System Framework, KMed Assets, etc.)

Regulatory and / or Organisational Requirements

Excellent knowledge of applicable global, regional and local PV regulations, BI processes and relevant GxP requirements.
Be compliant and acts within ethics at all times.

Job Complexity
The position requires extensive regulatory,scientific knowledge and balanced risk-based decision making. This needs to take into account needs and requirements of other functions, departments and units.

Interfaces
Local Medical Director, Global Patient Safety & Pharmacovigilance, MSG,CDMAs, LRA, MKT, SL, RWD
GRA, CD&O

① バリデーションマスタープランの作成
② リスクアセスメントの実施
③ DQ/IQ/OQ等の計画並びに報告書の作成
④ FAT/SAT実施管理
⑤ バリデーション進捗管理

1 監査プロセス
• 研究開発およびメディカルアフェアーズベンダー、臨床試験プロトコルおよびプロセスのリスク評価に基づき、戦略を策定し、年間グローバルGCP/GLP監査計画の策定を主導する。
• GCP/GLP監査チームリーダー及びチームメンバーを監督し、臨床試験実施施設、ベンダー/CRO、内部システム/プロセス、臨床データ及び文書、監査対応のレビュー、CAPAの完了までの追跡など、タイムリーで適切に作成された査読済み報告書の作成を管理する。
• GCP/GLP品質システムの継続的改善と強化を、グローバル指標の策定および「監査・査察から得られた教訓」の主導を通じて確保する。
• 潜在的な品質関連リスクについて、グローバル監査・査察およびR&D品質責任者に対し継続的なフィードバックを提供する。
• GCP/GLP 監査で特定されたギャップの管理について、研究開発部門責任者に継続的なフィードバックを提供する。
• ジュニアチームマネージャーおよび監査員を指導・育成し、進捗状況をレビューして経営陣にフィードバックを提供するとともに、必要に応じて個別研修イニシアチブの提供を監督する。
• グローバル監査・査察・R&D品質責任者の指示に基づき、追加の品質保証業務を遂行する。
2 グローバル、地域、ローカルの標準業務手順書（SOP）および作業指示書（WI）の監督と戦略立案
• プロセス改善イニシアチブを主導し、GCP/GLP QA SOP の開発・管理、および品質文書管理システムにおける GCP/GLP QA 管理文書の維持管理を推進する。
• 研究開発部門が、適用される要件および規制に準拠し、協和キリンの社内プロセスを反映したSOP/WIを開発し、GCP/GLP監査指摘事項に対処するために開始されたCAPAを実施する際に、R&D QAが提供するサポートを監督する。
• 協和キリンの研究開発部門内に継続的改善の考え方を醸成する。
3 臨床試験サポート
• 事業に GCP/GLP QA の専門知識を提供するために構築された構造の調和を推進し、地域間の一貫性とリソースの効率的な活用を確保する。
• 研究開発部門の臨床担当責任者が、全地域における全ての臨床試験にGCP品質責任者を割り当てることを確保する。
• 割り当てられた臨床試験について、チームが現在のGCP/GLPガイドラインおよび規制に関連する適切なGCPおよびGLP/信頼性基準ガイダンスを臨床試験チームに提供することを確保する。
• 必要に応じて、研究開発部門が所有し作成するプロセスに対して追加サポートおよびGCPガイダンス/インプットを提供する。
• 各研究開発機能責任者による品質行動の採用を促進する。
• 直属の部下と、各グローバルおよび地域の品質リーダー、臨床品質コンプライアンス責任者との連携を監督する。
• 意思決定プロセスへの品質面でのインプットを、責任を持って行い、GCP/GLPコンプライアンスを確保する。
• 品質窓口として、GCP QA の関与が必要なプロジェクトにリソースが割り当てられるよう確保する。
• GCP/GLP/R&D QAチームが、GCPおよび関連規制、GCP/GLP監査から得られた教訓、GCP QAまたはR&Dパートナーによって特定されたギャップに関するトレーニングを開発し、提供することを主導し、確実に実施する。
4 査察および規制当局査察の管理を支援する
• 国内および国際プロジェクト（該当する場合）におけるGCP規制当局査察活動を主導する。
• GCP/GLP/ R&D QAチームによるGCP査察準備を監督する
• 研究開発部門に対するGCP査察対応トレーニングの実施を監督し、模擬査察を手配する。
• 研究開発部門が策定する是正措置および予防措置（CAPA）を監督し、意見を提供する。
• GCP/GLP/R&DQAチームが、査察対象の臨床試験チームとの間でCAPAの策定、実施、完了のフォローアップを確実に行う。

＊本ポジションの魅力
本ポジションは、3つのサブグループ（GCP／GLP監査、R&D QA クリニカル、R&D QA ノンクリニカル）で構成される30名超のFTEから成るグローバル組織を率い、グローバルGCP／GLP監査戦略および監査計画の策定・実行を担うとともに、R&Dのステークホルダーに対してGCPに関するQAの専門性を提供します。主な責務には、以下のようなものがあります。

■グローバルGCP／GLP監査チームをリードし、すべての地域において監査の実施方法やリスク／ギャップの特定に一貫性を持たせるための監査基準およびベストプラクティスを設定する。
■GCP／GLP品質保証システムおよびプロセスの継続的な改善、R&Dのビジネスパートナーに対するGCPガイダンスやトレーニングの提供、逸脱およびCAPAの承認、ならびにレギュラトリーインテリジェンス活動への参画。

本ポジションは、治験および／または医薬品の承認申請を支援するために規制当局へ提出される科学データの正確性および品質を担保できるGCP／GLP監査プログラムを確実に機能させる役割を持ちます。また、協和キリンのR&D機能と緊密に連携し、パートナーシップを築くことも必要とされます。さらに、グローバルな業界動向、GCP／GLP規制に関する高度な知識を維持し、臨床試験を支援するために、協和キリンのスタッフに対して専門的な助言およびガイダンスを提供します。

この役割を果たすことにより、GCP／GLP品質保証に関する、部署をまたいだグローバルな経験や、地域をまたいだ組織マネジメントの経験を積むことができます。

職務内容

日本における医薬品（化学合成品、バイオ医薬品）の新規申請及び承認取得後のCMC薬事に関連する下記業務に責任を持つグループの責任者

・申請戦略・申請計画のCMCパートについて立案・遂行
・薬事関連の当局相談に係る戦略策定及び遂行
・製造販売承認申請業務（CMCパート）
・導入案件のCMC薬事関連の評価
・グループメンバーの教育訓練及び人財育成

Job Description
As a leader of Japan CMC & Devices RA New Drug Application group, lead the group to fulfill expected roles and responsibilities according to Global RA vision/mission and Company’s vision/mission/value.

・Oversee the development and execution of regulatory CMC development and registration strategies of all assigned products throughout clinical development and NDA approval.
・Successfully communicate and negotiate with Health Authorities as necessary, directly and indirectly, especially when difficult discussions are anticipated.
・Develop constructive relationships with and proactively escalate potentially critical issues to key internal and external stakeholders, including Alliance Partners.
・Demonstrate high level of leadership and expert understanding of global RA CMC regulations and guidelines and provide guidance to direct reports and all group members for their training and developments.
・Lead a group of individuals to support group’s goals according to agreed timelines, standards and business priorities

職務内容

日本における医薬品（化学合成品、バイオ医薬品）の新規申請及び承認取得後のCMC薬事に関連する下記業務に責任を持つグループの責任者

・申請戦略・申請計画のCMCパートについて立案・遂行
・薬事関連の当局相談に係る戦略策定及び遂行
・製造販売承認申請業務（CMCパート）
・導入案件のCMC薬事関連の評価
・グループメンバーの教育訓練及び人財育成

Job Description
As a leader of Japan CMC & Devices RA New Drug Application group, lead the group to fulfill expected roles and responsibilities according to Global RA vision/mission and Company’s vision/mission/value.

・Oversee the development and execution of regulatory CMC development and registration strategies of all assigned products throughout clinical development and NDA approval.
・Successfully communicate and negotiate with Health Authorities as necessary, directly and indirectly, especially when difficult discussions are anticipated.
・Develop constructive relationships with and proactively escalate potentially critical issues to key internal and external stakeholders, including Alliance Partners.
・Demonstrate high level of leadership and expert understanding of global RA CMC regulations and guidelines and provide guidance to direct reports and all group members for their training and developments.
・Lead a group of individuals to support group’s goals according to agreed timelines, standards and business priorities

（Purpose）

Leveraging a proven track record of leading at least 3 discovery programs to clinic, The Global Therapeutic Research Lead (G-TRL) is a pipeline critical strategic leader responsible for driving Research projects to the clinic. The individual will sit on the Neuroscience Drug Discovery Unit (NS DDU) Leadership Team.
Leader for at least one or more of Takeda’s top priority oligonucleotide projects with substantial clinical and commercial potential with a clear accelerated path to the clinic.
You will provide mentorship to team members to elevate enterprise thinking and capabilities of our drug discovery talent across the global Research function.
As project lead, the G-TRL builds a connected view of the project within the Neuroscience TA strategy and treatment paradigm and can represent all core expertise at depth and align with stakeholders and sponsors across the organization including Research, Clinical Development and Commercial stakeholders and executive level governance committees.
G-TRLs are responsible for creating the medicine vision, early asset strategy and managing multiple external partnerships that accelerate delivery of the project.
G-TRLs will establish smart, fast, and critical path minded practices for groups, including integrating new strategies and competitive industry ways of working.
G-TRL will advise on the continuous infusion of new Research projects aligned to strategy to generate a sustainable Research Engine generating a steady flow of high-quality INDs every year.

（Accountabilities）

Lead and manage one or more ‘Top 10’ drug discovery oligonucleotide projects, overseeing the entire drug discovery process from target identification to preclinical development. (Top 10 projects are well validated targets that are focused on strategically aligned modalities with substantial clinical and commercial potential)
Responsible for the articulation and ownership of the project strategy, developed in partnership with internal stakeholders.
Contribute to strategy for future portfolio investment, particularly within the Inflammation and Immunology area including advising on which projects should be Top 10 projects.
Evaluate and prioritize potential drug candidates based on scientific, medical, and commercial considerations.
Represent all core expertise for project.
Partner with Clinical and Translational teams to refine asset strategy.
Ensure alignment to the therapeutic area strategy (i.e., Clinical Development).
Understand and align with commercial team for asset commercial value within the Neuroscience Therapeutic Area (NS TA).
Provide guidance and mentorship to global project team members, stimulating enterprise thinking and fostering their professional growth and development.
Mentor future and more junior project leads and elevate drug discovery capability across Research.
Collaborate with cross-functional teams and partners (e.g., DMPK, Pharmaceutical Sciences) within and outside Takeda to drive project delivery.
Pipeline and enterprise impact through effective partnering with multiple internal and external collaborators.
Provide strategic, process, and operational leadership for successful Top 10 Project delivery.
Foster a culture of innovation and scientific excellence within the matrixed drug discovery team, promoting collaboration, knowledge sharing, and continuous learning.
Become a world leading scientific expert in the projects you lead.
Oversee the design and execution of experiments, data analysis, and interpretation to enable decision-making and optimize drug discovery efforts.
Stay abreast of the latest advancements in drug discovery, emerging technologies, and industry trends, applying this knowledge to enhance drug discovery strategies.
Build and maintain relationships with key stakeholders, including academic institutions, research organizations, and industry partners inclusive of serving on joint external governance committees across the globe.
Represent Takeda externally for the Neuroscience Drug Discovery Unit and play a key role in evaluating external opportunities, serving as an effective ambassador for Takeda’s global business development brand.

Job Description
”Better Health for People, Brighter Future for the World” is the purpose of a company. We aim to create a diverse and inclusive organization where people can thrive, grow and realize their own potential while enabling our purpose. We continue to innovate and drive changes that will transform the lives of patients. We’re looking for like-minded professionals to join us.

Takeda is a global values-based, R&D-driven biopharmaceutical leader. We are guided by our values of Takeda-ism, which has been passed down since the company’s founding. Takeda-ism incorporates Integrity, Fairness, Honesty, and Perseverance, with Integrity at the core. They are brought to life through actions based on Patient-Trust-Reputation-Business, in this order.
・Provide statistical support for Takeda preclinical campaigns for design and analysis in the discovery and development of targets and molecules for one or more disease areas.
・Collaborate with Computational Biology, Pharmacokinetics, and Safety scientists to explore methods and implement discovery strategies to enable data-driven decision making.
・Apply frequentist, Bayesian, ML/AI fit-for-purpose statistical analyses across various projects and data types.
・Serve as an expert and mentor in Quantitative Sciences group within implementing statistical development strategies using statistics and cross-disciplinary integrative data analytics.

Accountabilities:
・Lead implementation of SQS strategies and ensure deliverables by representing data science function on project teams in support of preclinical studies throughout the drug discovery units and supporting functions.
・Perform end-to-end data analyses, from hypotheses formulation, experimental design, writing analysis plans, data cleaning, executing analysis, and preparing reports and documentation.
・Strengthen Takeda’s advanced analytics toolkit by identifying, promoting, and applying emerging techniques, as well as by developing novel analysis tools as needed.
・Collaborate effectively within a matrix environment, working with scientists across various areas to understand the problems in terms of its chemistry, biology, and/or physical natures and to tailor data analyses to program-specific needs.
・Work closely with Takeda statisticians to ensure statistical issues in data analysis are addressed.
・Communicate internal and external resource and quality issues that may impact deliverables or timelines of the program. Escalate issues to management as appropriate in a timely manner.
・Respond to regulatory questions that are statistical in nature.
・Increase the external recognition of Takeda’s data science work by participating in conferences, publishing work and developing external collaborations.

Job Description Summary
医薬品や再生医療等製品の初期開発段階からプロジェクトチームに参画し、承認取得までの期間を通し、薬事戦略の立案やそれに基づく開発プランの作成、規制当局（MHLW, PMDA）との折衝、Globalと協働しながら世界同時開発、申請/承認をドライブしていくことができます。

Job Description
業務内容：
•医薬品の初期開発段階からプロジェクトチームに参画し、承認取得までの期間を通し、薬事戦略の立案、それに基づく開発プランの作成について中心的な役割を果たし薬事的リスクマネジメントを行う。
•規制当局（PMDA, MHLW) 対応をリードし、プロジェクトチームの代表として関係当局との交渉に責任を持つ。例：開発プロジェクトの承認申請チームのリード
•Globalと協同し、世界同時開発・同時申請・同時承認の達成をドライブする。
• 各部門の担当者等と協働し、Product Life Cycle Planの最大化に貢献する。

業務のやりがい：
•開発早期から承認取得、市販後まで薬の一生に幅広く関わることができる
•規制や業界の流れを正しく読み取り、将来的な変化を見越した薬事戦略の立案/実行をリードできる
•社内外の顧客や海外の開発関連部署など多くのメンバーと多岐にわたる仕事に携われる
•個人としての作業に加えて、チームメンバーとの協働を通じて、申請・承認などの大きなマイルストーンも経験できる
•社内外や規制当局も巻き込んで、AIやITテクノロジーを活用した先進的な医薬品開発を推進していくイノベーティブな活動にも参画できる